Literature DB >> 22471279

Prognostic importance of tumour-infiltrating memory T cells in oesophageal squamous cell carcinoma.

K Enomoto1, M Sho, K Wakatsuki, T Takayama, S Matsumoto, S Nakamura, T Akahori, T Tanaka, K Migita, M Ito, Y Nakajima.   

Abstract

Memory T cells survive for many months and years and are critically important for host defence in humans. In tumour immunity, they have been also suggested to play a significant role in tumour progression and metastasis. However, the role of memory T cells in actual human cancer remains largely unknown. In this study, the clinical importance of tumour-infiltrating CD45RO(+) memory T cells was investigated in human oesophageal squamous cell carcinoma (OSCC). CD45RO(+) T cells were evaluated by immunohistochemistry in primary OSCC tumours from 105 patients. Patients were classified into two groups as CD45RO(+hi) or CD45RO(+lo) based on the number of cells stained positively for CD45RO. No significant difference was observed between CD45RO status and several clinicopathological prognostic factors. However, the postoperative overall and disease-free survival for CD45RO(+hi) patients was significantly better than for CD45RO(+lo) patients. Furthermore, there were significant correlations of CD45RO status in the primary tumour with postoperative lymph node and pulmonary recurrence, suggesting that memory T cells may control postoperative metastatic recurrence. Most importantly, CD45RO(+) memory T cell status has a significant prognostic value for OSCC independently of conventional tumour-node-metastasis (TNM) classification. Our study may provide a rationale for developing a novel immunotherapy in intentional induction of memory T cells for the treatment of oesophageal cancer.
© 2012 The Authors;Clinical and Experimental Immunology © 2012 British Society for Immunology.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22471279      PMCID: PMC3390519          DOI: 10.1111/j.1365-2249.2012.04565.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  34 in total

Review 1.  A new era for cancer immunotherapy based on the genes that encode cancer antigens.

Authors:  S A Rosenberg
Journal:  Immunity       Date:  1999-03       Impact factor: 31.745

2.  Effector memory T cells, early metastasis, and survival in colorectal cancer.

Authors:  Franck Pagès; Anne Berger; Matthieu Camus; Fatima Sanchez-Cabo; Anne Costes; Robert Molidor; Bernhard Mlecnik; Amos Kirilovsky; Malin Nilsson; Diane Damotte; Tchao Meatchi; Patrick Bruneval; Paul-Henri Cugnenc; Zlatko Trajanoski; Wolf-Herman Fridman; Jérôme Galon
Journal:  N Engl J Med       Date:  2005-12-22       Impact factor: 91.245

Review 3.  The role of MHC class II-restricted tumor antigens and CD4+ T cells in antitumor immunity.

Authors:  R F Wang
Journal:  Trends Immunol       Date:  2001-05       Impact factor: 16.687

Review 4.  Intrinsic and extrinsic control of peripheral T-cell tolerance by costimulatory molecules of the CD28/ B7 family.

Authors:  Hélène Bour-Jordan; Jonathan H Esensten; Marc Martinez-Llordella; Cristina Penaranda; Melanie Stumpf; Jeffrey A Bluestone
Journal:  Immunol Rev       Date:  2011-05       Impact factor: 12.988

5.  The Fas counterattack in vivo: apoptotic depletion of tumor-infiltrating lymphocytes associated with Fas ligand expression by human esophageal carcinoma.

Authors:  M W Bennett; J O'Connell; G C O'Sullivan; C Brady; D Roche; J K Collins; F Shanahan
Journal:  J Immunol       Date:  1998-06-01       Impact factor: 5.422

6.  Clinical significance of programmed death-1 ligand-1 and programmed death-1 ligand-2 expression in human esophageal cancer.

Authors:  Yuichiro Ohigashi; Masayuki Sho; Yukishige Yamada; Yoshikazu Tsurui; Kaoru Hamada; Naoya Ikeda; Takashi Mizuno; Ryo Yoriki; Hisanori Kashizuka; Katsunari Yane; Fumihiko Tsushima; Noriko Otsuki; Hideo Yagita; Miyuki Azuma; Yoshiyuki Nakajima
Journal:  Clin Cancer Res       Date:  2005-04-15       Impact factor: 12.531

Review 7.  Novel targeted therapies in the treatment of gastric and esophageal cancer.

Authors:  J Tabernero; T Macarulla; F J Ramos; J Baselga
Journal:  Ann Oncol       Date:  2005-06-24       Impact factor: 32.976

8.  Increased populations of regulatory T cells in peripheral blood and tumor-infiltrating lymphocytes in patients with gastric and esophageal cancers.

Authors:  Fumiko Ichihara; Koji Kono; Akihiro Takahashi; Hiromichi Kawaida; Hidemitsu Sugai; Hideki Fujii
Journal:  Clin Cancer Res       Date:  2003-10-01       Impact factor: 12.531

9.  Lifespan of human lymphocyte subsets defined by CD45 isoforms.

Authors:  C A Michie; A McLean; C Alcock; P C Beverley
Journal:  Nature       Date:  1992-11-19       Impact factor: 49.962

Review 10.  Tumor antigens recognized by T lymphocytes.

Authors:  T Boon; J C Cerottini; B Van den Eynde; P van der Bruggen; A Van Pel
Journal:  Annu Rev Immunol       Date:  1994       Impact factor: 28.527

View more
  16 in total

1.  Tumor-infiltrating memory T-lymphocytes for prognostic prediction in cancer patients: a meta-analysis.

Authors:  Qingzhu Jia; Yi Yang; Ying Wan
Journal:  Int J Clin Exp Med       Date:  2015-02-15

2.  Synergy effects of Polyinosinic-polycytidylic acid, CpG oligodeoxynucleotide, and cationic peptides to adjuvant HPV E7 epitope vaccine through preventive and therapeutic immunization in a TC-1 grafted mouse model.

Authors:  Cunbao Liu; Xiaojie Chu; Pengyan Sun; Xuejun Feng; Weiwei Huang; Hongxian Liu; Yanbing Ma
Journal:  Hum Vaccin Immunother       Date:  2018-01-23       Impact factor: 3.452

3.  Memory CD4+ T cell subsets in tumor draining lymph nodes of breast cancer patients: A focus on T stem cell memory cells.

Authors:  Yasmin Vahidi; Zahra Faghih; Abdol-Rasoul Talei; Mehrnoosh Doroudchi; Abbas Ghaderi
Journal:  Cell Oncol (Dordr)       Date:  2017-10-09       Impact factor: 6.730

4.  Enhanced local and systemic anti-melanoma CD8+ T cell responses after memory T cell-based adoptive immunotherapy in mice.

Authors:  Amanda Contreras; Siddhartha Sen; Andrew J Tatar; David A Mahvi; Justin V Meyers; Prakrithi Srinand; Marulasiddappa Suresh; Clifford S Cho
Journal:  Cancer Immunol Immunother       Date:  2016-03-24       Impact factor: 6.968

5.  Association between the genetic variations within TBX21 gene promoter and the clinicopathological characteristics of esophageal squamous cell carcinoma in a high-risk Chinese population.

Authors:  Huihui Li; Hongchao Zhen; Lei Han; Bo Yan; Jing Yu; Shengtao Zhu; Bangwei Cao
Journal:  Tumour Biol       Date:  2015-01-11

6.  [CD45RO⁺ Memory T Lymphocytes As A Candidate Marker for Non-small Cell Lung Cancer].

Authors:  Qifan Tan; Haoyang Li; Mengjun Yu; Xiaonan Tang; Jinjing Tan; Shucai Zhang; Jinghui Wang
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2021-04-20

7.  Endothelin B receptor expression correlates with tumour angiogenesis and prognosis in oesophageal squamous cell carcinoma.

Authors:  T Tanaka; M Sho; T Takayama; K Wakatsuki; S Matsumoto; K Migita; M Ito; K Hamada; Y Nakajima
Journal:  Br J Cancer       Date:  2013-12-19       Impact factor: 7.640

8.  Nectin-4 expression contributes to tumor proliferation, angiogenesis and patient prognosis in human pancreatic cancer.

Authors:  Satoshi Nishiwada; Masayuki Sho; Satoshi Yasuda; Keiji Shimada; Ichiro Yamato; Takahiro Akahori; Shoichi Kinoshita; Minako Nagai; Noboru Konishi; Yoshiyuki Nakajima
Journal:  J Exp Clin Cancer Res       Date:  2015-03-28

9.  ROS Cocktails as an Adjuvant for Personalized Antitumor Vaccination?

Authors:  Ramona Clemen; Sander Bekeschus
Journal:  Vaccines (Basel)       Date:  2021-05-19

10.  CD45RO(+) Memory T Lymphocytes--a Candidate Marker for TNM-Immunoscore in Squamous Non-Small Cell Lung Cancer.

Authors:  Erna-Elise Paulsen; Thomas Kilvaer; Mehrdad Rakaee Khanehkenari; Ramona Johansen Maurseth; Samer Al-Saad; Sigurd M Hald; Khalid Al-Shibli; Sigve Andersen; Elin Richardsen; Lill-Tove Busund; Roy Bremnes; Tom Donnem
Journal:  Neoplasia       Date:  2015-11       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.